Home Biosimilar Antibodies Cytoskeletal Signaling Integrin Bersanlimab (Anti-ICAM1 / CD54)
For research use only. Not for use in humans.

Bersanlimab (Anti-ICAM1 / CD54)

Synonyms: BI-505

Bersanlimab (Anti-ICAM1 / CD54) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects. MW: 145.5 KD.

Bersanlimab (Anti-ICAM1 / CD54)

Quality Control

Batch: A246401 Purity: 99% Protein concentration: 6.977mg/ml Endotoxin Level: ＜1EU/mg
99

Specificity

Name Citation Integrin ILK Others
Cilengitide trifluoroacetate 70
A-205804 6
GLPG0187 1
GSK-3008348 HCl 0
Bexotegrast (PLN-74809) 0
Cilengitide (EMD 121974) 36
OSU-T315 1
TR-14035 0
Cyclo(RGDyK) TFA 14
SB273005 27
RGD peptide (Arg-Gly-Asp) 26
ILK-IN-3 0
RGD peptide (GRGDNP) 1 caspase-3
ATN-161 22
Cyclo(-RGDfK) TFA 13
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Bersanlimab (Anti-ICAM1 / CD54) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects. MW: 145.5 KD.

Product Details

CAS No. 1987854-08-9
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.